SCHEMBL9309622

SCHEMBL9309622

CCc1nc(C)c(C(=O)NC)n1Cc1ccc2oc(-c3ccccc3-c3nnn(C(c4ccccc4)(c4ccccc4)c4ccccc4)n3)c(Br)c2c1.O=C(n1ccnc1)n1ccnc1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9859391 0.93 AGTR1 (0.48) AGTR1
SCHEMBL9309889 0.86 AGTR1 (0.55) AGTR1
SCHEMBL9312340 0.86 AGTR1 (0.54) AGTR1
SCHEMBL9695376 0.84 AGTR1 (0.46) AGTR1
SCHEMBL9318947 0.82 AGTR1 (0.45) AGTR1
SCHEMBL9693668 0.81 AGTR1 (0.48) AGTR1
SCHEMBL9311404 0.81 AGTR1 (0.59) AGTR1
SCHEMBL9310688 0.81 AGTR1 (0.47) AGTR1
SCHEMBL9310042 0.81 AGTR1 (0.47) AGTR1
SCHEMBL9309381 0.81 AGTR1 (0.64) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5374646-A Treatment or prophylasix of hypertension and diseases associated with cognitive disorders GLAXO GROUP LIMITED (GB) 1994-12-20 US disclosed